Is Adaptive Biotechnologies Corporation (ADPT) a Buy, Sell, or Hold?
Adaptive Biotechnologies Corporation
NASDAQ:ADPT
$22.9 USD
$1.47 (6.86%)
- Volume
- 3.98M
- Average Volume
- 2.52M
- Market Capitalization
- $916.25M
- P/E Ratio
- -17.49
- Dividend Yield
- 0.00%
- Price Target
- $21.50
- Year High
- $22.99
- Year Low
- $9.96
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.35
Analyst Rating
Strong Sell
1 Rating Score
UPSIDE/DOWNSIDE
6.5% UPSIDE
$21.50 Price Target
UPSIDE/DOWNSIDE HIGH
4.1% UPSIDE
$22.00 Price Target High
UPSIDE/DOWNSIDE LOW
14.5% UPSIDE
$20.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Piper Sandler | Sebastian Sandler | $21 | $16.47 | 2026-02-06 06:48 AM | 27.5% |
| Morgan Stanley | Kallum Titchmarsh | $21 | $18.84 | 2025-12-01 04:27 PM | 11.5% |
| BTIG | Mark Massaro | $5 | $2.68 | 2024-04-04 02:39 AM | 86.6% |
| Piper Sandler | David Westenberg | $14 | $7.09 | 2022-12-20 11:43 PM | 97.5% |